These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21178622)

  • 1. Use of prokinetics in the preterm infant.
    Lam HS; Ng PC
    Curr Opin Pediatr; 2011 Apr; 23(2):156-60. PubMed ID: 21178622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oral erythromycin for the treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC
    Neonatology; 2009; 95(2):97-104. PubMed ID: 19218823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin and feeding intolerance in premature infants: a randomized trial.
    Aly H; Abdel-Hady H; Khashaba M; El-Badry N
    J Perinatol; 2007 Jan; 27(1):39-43. PubMed ID: 17036029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral erythromycin for treatment of feeding intolerance in preterm infants: a preliminary report.
    Sekteera W; Nuntnarumit P; Supapannachart S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1177-82. PubMed ID: 12549792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2000; (2):CD001815. PubMed ID: 10796273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin treatment for gastrointestinal dysmotility in preterm infants.
    Ng PC; Fok TF; Lee CH; Wong W; Cheung KL
    J Paediatr Child Health; 1997 Apr; 33(2):148-50. PubMed ID: 9145359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants.
    Mansi Y; Abdelaziz N; Ezzeldin Z; Ibrahim R
    Neonatology; 2011; 100(3):290-4. PubMed ID: 21701222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2001; (2):CD001815. PubMed ID: 11406010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.
    Ng E; Shah VS
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001815. PubMed ID: 18646077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC; So KW; Fung KS; Lee CH; Fok TF; Wong E; Wong W; Cheung KL; Cheng AF
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F177-82. PubMed ID: 11320044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants.
    Oei J; Lui K
    Acta Paediatr; 2001 Aug; 90(8):904-8. PubMed ID: 11529540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin as a prokinetic agent in preterm neonates: a systematic review.
    Patole S; Rao S; Doherty D
    Arch Dis Child Fetal Neonatal Ed; 2005 Jul; 90(4):F301-6. PubMed ID: 15899929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythromycin as a prokinetic agent in newborns--useful or doubtful. Commentary on Y. Mansi et al.: Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants (Neonatology 2011;100:290-294).
    Ng PC
    Neonatology; 2011; 100(3):297-8. PubMed ID: 21701224
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants.
    ElHennawy AA; Sparks JW; Armentrout D; Huseby V; Berseth CL
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):281-6. PubMed ID: 12960650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants.
    Nuntnarumit P; Kiatchoosakun P; Tantiprapa W; Boonkasidecha S
    J Pediatr; 2006 May; 148(5):600-5. PubMed ID: 16737869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks.
    Hawkyard CV; Koerner RJ
    J Antimicrob Chemother; 2007 Mar; 59(3):347-58. PubMed ID: 17289772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants.
    Ng PC; Lee CH; Wong SP; Lam HS; Liu FY; So KW; Lee CY; Fok TF
    Gastroenterology; 2007 May; 132(5):1726-39. PubMed ID: 17484870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motility disorders in the ICU: recent therapeutic options and clinical practice.
    Röhm KD; Boldt J; Piper SN
    Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):161-7. PubMed ID: 19202387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin as a prokinetic agent.
    Kaul A
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):13-5. PubMed ID: 11753157
    [No Abstract]   [Full Text] [Related]  

  • 20. Can prophylactic oral erythromycin reduce time to full enteral feeds in preterm neonates?
    Patole SK; Almonte R; Kadalraja R; Tuladhar R; Muller R; Whitehall JS
    Int J Clin Pract; 2000 Oct; 54(8):504-8. PubMed ID: 11198727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.